CA
AMED

Clearstead Advisors’s Amedisys AMED Stock Holding History

Clearstead Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-80
Closed -$7.87K – 3095
2025
Q2 		$7.87K Buy
80
+75
+1,500% +$7.1K ﹤0.01% 1967
2025
Q1 		$464 Buy
+5
New +$461 ﹤0.01% 2078

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Clearstead Advisors's AMED Position: Q3 2025 in Review

Clearstead Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 80 shares — an estimated $7.87K sold.

Clearstead Advisors first reported a position in AMED in Q1 2025 and held it in 2 quarters. The position peaked at $7.87K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Clearstead Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Clearstead Advisors sold 80 Amedisys shares in Q3 2025, an estimated $7.87K.
  • Clearstead Advisors first reported a position in Amedisys in Q1 2025 and held it in 2 quarters.
  • Clearstead Advisors's Amedisys position peaked at $7.87K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.